Prolintane

Prolintane

Prolintane is a stimulant drug that belongs to the amphetamine class. It was developed in the 1950s and has been used for therapeutic purposes, but is not widely used today due to its potential for abuse and addiction.

History

Prolintane was first synthesized in the 1950s by the pharmaceutical company Vitapharm. It was marketed as a treatment for a variety of conditions, including narcolepsy, depression, and chronic fatigue syndrome. However, due to its amphetamine-like effects, it quickly gained popularity as a recreational drug.

Pharmacology

Prolintane acts as a norepinephrine-dopamine reuptake inhibitor, meaning it increases the levels of these neurotransmitters in the brain by preventing their reuptake into neurons. This results in increased alertness, focus, and energy, similar to other stimulant drugs.

Side Effects

The side effects of Prolintane can include insomnia, anxiety, agitation, and psychosis in high doses. Long-term use can lead to drug dependence and withdrawal symptoms upon cessation.

Legal Status

In many countries, Prolintane is a controlled substance due to its potential for abuse and addiction. However, it is still available in some countries for medical use under strict regulations.

See Also

• Amphetamine
• Stimulant
• Norepinephrine-dopamine reuptake inhibitor

This article is a stub related to pharmacology. You can help WikiMD by expanding it!

This stimulant-related article is a stub. You can help WikiMD by expanding it.

   This article is a Amphetamine-related stub. You can help WikiMD by expanding it!